Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones

Jan 09, 2025

DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 1.27% to $12.44 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.25% to 42,635.20 and the NASDAQ Composite Index falling 0.06% to 19,478.88.

This was the stock's third consecutive day of losses.

Corbus Pharmaceuticals Holdings Inc. closed $49.46 short of its 52-week high ($61.90), which the company reached on July 31st.

Despite its losses, the stock outperformed some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 4.12% to $4.65, Fortress Biotech Inc. (FBIO) fell 3.26% to $2.08, and Viking Therapeutics Inc. $(VKTX)$ fell 2.54% to $40.60.

Trading volume (119,069) remained 184,334 below its 50-day average volume of 303,403.

Data source: Dow Jones Market Data, FactSet. Data compiled January 8, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

January 08, 2025 17:31 ET (22:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2502081913"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2502081913\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2502081913?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-09 06:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2502081913","market":"us","top_or_hot":-1,"title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Corbus Pharmaceuticals Holdings Inc. <a href=\"https://laohu8.com/S/CRBP\">$(CRBP)$</a> slipped 1.27% to $12.44 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.25% to 42,635.20 and the NASDAQ Composite Index  falling 0.06% to 19,478.88. \n</p>\n<p>\n     This was the stock's third consecutive day of losses. \n</p>\n<p>\n     Corbus Pharmaceuticals Holdings Inc. closed $49.46 short of its 52-week high ($61.90), which the company reached on July 31st. \n</p>\n<p>\n     Despite its losses, the stock outperformed some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VNDA\">$(VNDA)$</a> fell 4.12% to $4.65, <a href=\"https://laohu8.com/S/FBIO\">Fortress Biotech Inc.</a> (FBIO) fell 3.26% to $2.08, and Viking <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc. <a href=\"https://laohu8.com/S/VKTX\">$(VKTX)$</a> fell 2.54% to $40.60. \n</p>\n<p>\n     Trading volume (119,069) remained 184,334 below its 50-day average volume of 303,403. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled January 8, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 08, 2025 17:31 ET (22:31 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCorbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-01-09 06:31</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Corbus Pharmaceuticals Holdings Inc. <a href=\"https://laohu8.com/S/CRBP\">$(CRBP)$</a> slipped 1.27% to $12.44 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.25% to 42,635.20 and the NASDAQ Composite Index  falling 0.06% to 19,478.88. \n</p>\n<p>\n     This was the stock's third consecutive day of losses. \n</p>\n<p>\n     Corbus Pharmaceuticals Holdings Inc. closed $49.46 short of its 52-week high ($61.90), which the company reached on July 31st. \n</p>\n<p>\n     Despite its losses, the stock outperformed some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VNDA\">$(VNDA)$</a> fell 4.12% to $4.65, <a href=\"https://laohu8.com/S/FBIO\">Fortress Biotech Inc.</a> (FBIO) fell 3.26% to $2.08, and Viking <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc. <a href=\"https://laohu8.com/S/VKTX\">$(VKTX)$</a> fell 2.54% to $40.60. \n</p>\n<p>\n     Trading volume (119,069) remained 184,334 below its 50-day average volume of 303,403. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled January 8, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 08, 2025 17:31 ET (22:31 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRBP","symbol_name":"Corbus Pharmaceuticals Holdings, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2502081913","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2502081913","pubTimestamp":1736375460,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slipped 1.27% to $12.44 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.25% to 42,635.20 and the NASDAQ Composite Index  falling 0.06% to 19,478.88.This was the stock's third consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed $49.46 short of its 52-week high , which the company reached on July 31st.Despite its losses, the stock outperformed some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  fell 4.12% to $4.65, Fortress Biotech Inc.  fell 3.26% to $2.08, and Viking Therapeutics Inc.  fell 2.54% to $40.60.Trading volume  remained 184,334 below its 50-day average volume of 303,403.Data source: Dow Jones Market Data, FactSet. Data compiled January 8, 2025.This content was created by MarketWatch, which is operated by Dow Jone","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"CRBP":"Corbus Pharmaceuticals Holdings, Inc."},"translate_title":"尽管当天下跌，Corbus Pharmaceuticals Holdings Inc.股票的表现仍优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRBP":1},"content_text":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 1.27% to $12.44 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.25% to 42,635.20 and the NASDAQ Composite Index  falling 0.06% to 19,478.88. \n\n\n     This was the stock's third consecutive day of losses. \n\n\n     Corbus Pharmaceuticals Holdings Inc. closed $49.46 short of its 52-week high ($61.90), which the company reached on July 31st. \n\n\n     Despite its losses, the stock outperformed some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 4.12% to $4.65, Fortress Biotech Inc. (FBIO) fell 3.26% to $2.08, and Viking Therapeutics Inc. $(VKTX)$ fell 2.54% to $40.60. \n\n\n     Trading volume (119,069) remained 184,334 below its 50-day average volume of 303,403. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled January 8, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 08, 2025 17:31 ET (22:31 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}